Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07854743 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Outcomes and Inter-Stage Interval in Staged Bilateral PCNL

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fields
  2. Study First Submitted
This prospective, single-center observational study evaluated patients undergoing staged bilateral standard percutaneous nephrolithotomy (PCNL) for bilateral renal stones. Each participant underwent PCNL on one kidney followed by contralateral PCNL in a separate session, allowing a paired within-patient comparison in which each patient served as their own control. The study aimed to compare operative, hematologic, renal, inflammatory, stone-free, and complication outcomes between the first and second PCNL procedures. In addition, the association between the inter-stage interval and second-side outcomes was explored, with particular emphasis on systemic inflammatory response assessed using neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII).
Trial Details
NCT Number NCT07854743
Lead Sponsor Ankara Training and Research Hospital
Conditions
(from sponsor)		 Nephrolithiasis
Related terms Acute Kidney Injury, Inflammation, Nephrolithiasis, Systemic Inflammatory Response Syndrome
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov